Condition
Kidney Transplantation clinical trials and research
As of November 12, 2026, Find a Trial lists 29 Kidney Transplantation clinical trials that are recruiting, at sites in 14 countries (most in United States (8), France (5), Spain (3)). 1 was first registered in the last 30 days. By phase: Phase 1/2 (4), Phase 2 (3), Phase 4 (2), Phase 3 (1). The most active sponsors are United Therapeutics (2), Nantes University Hospital (2). There are also 75 NIH-funded research projects on Kidney Transplantation, with $58.3 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 29Clinical trials
- 75NIH research projects
- 1New in 30 days
- 14Countries
Newest Kidney Transplantation clinical trials
All recruiting trials (29)
-
Italian Registry of Pediatric Dialysis: collecting data from kids on kidney replacement therapy
This registry in Italy tests how collecting epidemiological, clinical, and treatment data from children on dialysis or pre-emptive kidney transplants can help centers share protocols and improve care.
-
Intraoperative diuretics during deceased-donor kidney transplants
This trial tests whether using furosemide or mannitol during kidney transplant surgery affects delayed graft function in adults receiving a deceased-donor kidney.
-
Immune Reset to Enable Kidney Transplant for Highly Sensitized Patients
This study tests whether a temporary immune system reboot using a patient’s own stem cells can help highly sensitized kidney patients receive a compatible transplant.
-
Home-based exercise to boost fitness for people waiting for a kidney transplant
This study tests whether a 12-week, home-based exercise program plus a wearable activity tracker helps adults on the kidney transplant waiting list increase daily activity and improve physical function.
-
A six-week online self-management program for adults in Israel with chronic conditions
This six-week online group program will try to help adults in Israel who have chronic conditions—such as cancer survivors or kidney transplant recipients—learn practical skills to manage symptoms and daily health.
-
Vonoprazan to reduce delayed graft function after deceased-donor kidney transplant
This trial will test whether giving vonoprazan around the time of surgery lowers the chance of delayed graft function in adults receiving their first deceased-donor kidney transplant.
-
GGTA1 KO pig kidney with thymus for people with end-stage kidney failure
This test tries a genetically modified pig kidney with attached thymus tissue (GGTA1 KO Thymokidney) in people with end-stage kidney failure who either can't get a human donor kidney or are unlikely to get one within five years.
-
Prehabilitation program for kidney transplant candidates
This study is testing if using wearable sensors during exercise can help kidney transplant candidates get stronger and better prepared for their surgery.
-
10 GE Xenokidney transplant for people with end-stage kidney disease
This program will test whether a genetically engineered pig kidney (the 10 GE Xenokidney) can safely replace failed kidneys and help adults with end-stage renal disease who are either ineligible for or unlikely to receive a human transplant.
-
TTV-guided long-term immunosuppression in kidney transplant recipients
This trial tests whether checking Torque Teno Virus (TTV) levels every three months starting in the second year after transplant can help tailor immunosuppressive drugs for adult kidney transplant recipients to reduce infections, rejection, and cancer.
-
Dipyridamole to prevent low phosphate after kidney transplant
This study tests whether giving dipyridamole can help keep phosphate levels higher after a kidney transplant and reduce the need for phosphate supplements.
-
Identifying biomarkers in kidney disease before and after transplantation
This study is trying to find specific markers in urine, blood, and tissue that can help doctors better diagnose and predict kidney disease before and after a transplant.
-
Autologous expanded regulatory CD8+ T cell therapy for living-donor kidney transplant recipients
This trial will test whether infusing a patient's own expanded regulatory CD8+ T cells (Eight Treg) around a living-donor kidney transplant can help the graft survive better and lower the need for standard immunosuppressive drugs.
-
Monitoring glucose levels after kidney transplantation
This study looks at how glucose levels change in kidney transplant patients during the first two weeks after surgery to see if there are differences between those with diabetes, prediabetes, and no diabetes.
-
Evaluating the BETY-BQ Questionnaire for Chronic Kidney Disease and Transplant Patients
This study is testing a new questionnaire to see how well it helps understand the challenges faced by people with chronic kidney disease, those on dialysis, and kidney transplant patients.
-
Reduced immunosuppression for older kidney transplant recipients with TruGraf/TRAC monitoring
This study will see if stopping mycophenolate mofetil (MMF) in kidney transplant patients aged 55 and older, while using TruGraf/TRAC blood tests to watch for rejection and infections, is as safe as continuing the medication.
-
Regulatory T-cell therapy to reduce immunosuppression after a living-donor kidney transplant
This trial will test whether a single infusion of a patient's expanded regulatory T cells (TRK-001) after a living-donor kidney transplant lets people safely reduce their long-term anti-rejection medications.
-
Stopping calcineurin inhibitors in kidney transplant recipients with no HLA-DQ mismatch
This study is testing if kidney transplant patients with a good match can safely stop taking calcineurin inhibitors while adjusting their other medications to see how it affects their kidney health.
-
Home-based exercise program for kidney transplant recipients
This study is testing whether a home-based exercise program can help kidney transplant recipients improve their fitness and overall health compared to different levels of exercise intensity.
-
Using advanced MRI to assess kidney health in donors, recipients, and healthy individuals
This study is testing if advanced MRI scans can help check kidney health in living kidney donors, transplant recipients, and healthy people without needing a biopsy.
-
Ultrasound renal denervation for uncontrolled high blood pressure after kidney transplant
This study will try ultrasound renal denervation on the native kidneys to see if it lowers blood pressure in kidney transplant patients whose hypertension is not controlled by medicines.
-
Endoscopic sleeve gastroplasty for obese kidney transplant candidates
This study is testing if a procedure called endoscopic sleeve gastroplasty can help obese patients with kidney disease lose enough weight to qualify for a kidney transplant.
-
Using modified immune cells in living donor kidney transplantation
This study is testing a new treatment using modified immune cells to see if it helps people who are getting a kidney transplant from a living donor.
-
Using warm perfusion to improve kidney transplantation outcomes
This study is testing a new device that keeps kidneys warm and healthy before transplanting them to see if it helps improve the success of kidney transplants from deceased donors.
-
Assessing kidney blood flow changes after closing a fistula in transplant patients
This study is testing how closing a fistula affects blood flow in the kidneys of kidney transplant patients to see if it impacts their kidney function.
-
Extracorporeal phototherapy effects on T-follicular helper and B cells in chronic antibody-mediated kidney transplant rejection
This tests whether extracorporeal phototherapy (ECP) can change T-follicular helper and circulating B cells in adults with chronic antibody-mediated rejection after a kidney transplant.
-
Preventing incisional hernias after kidney transplantation
This study is testing if using a special mesh during kidney transplant surgery can help prevent hernias from forming afterward in patients receiving their first transplant.
-
Evaluating the Shingrix vaccine in kidney transplant recipients
This study tests how well the Shingrix vaccine works and its safety for people waiting for a kidney transplant.
-
Database for kidney transplantation research
This study is creating a large database to collect information on kidney transplant patients to help researchers understand their long-term health and improve treatment options.
NIH-funded research (newest 40 of 75)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Strategies for HIV-to-HIV kidney transplants to increase organ donations
This project looks at making HIV-to-HIV kidney transplantation more common to help people with HIV get transplants faster by boosting organ donation and changing practice.
-
Biomarker-guided Immunosuppression in Kidney Transplant Patients
A multicenter study in kidney transplant recipients is testing whether a biomarker score from HLA-DR/DQ can guide changes in immunosuppression to reduce rejection risk and drug toxicity.
-
Helping the immune system accept a donated kidney in patients without prior sensitization
This project will try giving specially treated donor B cells alongside immune-sparing medicines to teach the immune systems of kidney transplant patients without prior antibodies to accept the new kidney.
-
Lowering donor-specific antibodies in sensitized kidney transplant patients
This project works to reduce harmful donor-specific antibodies in people who are sensitized and need a kidney transplant so their new organ lasts longer.
-
Reducing geographic disparities in kidney transplant access with AI and operations research
Aiming to use AI and operations research to make kidney transplant access more fair across different regions in the U.S.
-
Centralized patient coaching to boost live donor kidney transplantation
A US-wide program trains patients, caregivers, and their networks with coaching to help them pursue living donor kidney transplantation.
-
Missed Pediatric Priority in Kidney Transplantation
This research aims to improve outcomes for children with kidney disease by focusing on when and how kidney transplantation can best help young patients.
-
RaDIANT Health Systems Intervention to Improve Kidney Transplant Access
This project aims to help adults with kidney failure in the Southeastern US get faster, better access to kidney transplant through coordinated education and system-wide changes.
-
Biomarker-guided changes in kidney transplant immunosuppression
This project tests whether a biomarker score from donor and recipient immune markers can guide safer, personalized immunosuppression after kidney transplant.
-
Patient-provider conversations and unequal access to home dialysis and kidney transplant
This project explores how conversations between doctors and patients affect why some Black and Hispanic people with kidney disease don’t get home dialysis or preemptive kidney transplants as often as White or Asian patients.
-
Innate immune sensing and genetic links to kidney transplant outcomes
This grant looks at how innate immune receptors and genetic variations relate to long-term kidney transplant success in diverse patients.
-
APOL1 Long-term Kidney Transplant Outcomes Network Center
This grant supports long-term follow-up and data collection from African American donors and transplant recipients to better understand how APOL1 gene variants affect kidney transplant outcomes.
-
A tool to help decide kidney transplants for people who had cancer
A patient-friendly tool will help doctors and patients understand how kidney transplant may affect survival for people with end-stage kidney disease who have a history of cancer.
-
Monocyte and Macrophage Roles in Kidney Transplant Health
This study looks at how monocytes and macrophages behave after kidney transplant to find ways to reduce rejection and long-term damage.
-
APOL1 Genetics and Kidney Transplant Outcomes in African Ancestry Donors and Recipients
This grant studies how donor APOL1 gene variants affect kidney transplant success, especially for recipients with African ancestry.
-
Preventing weight gain and blood sugar problems after kidney transplant
This project offers a diet and activity program for people who have had a kidney transplant to help prevent weight gain and problems with blood sugar.
-
APOL1 and Long-term Kidney Transplant Outcomes Network (APOLLO) Clinical Center
This grant supports a clinical center that studies how APOL1 gene variants and other factors affect kidney transplant survival in African American donors and recipients.
-
APOLLO: Understanding APOL1 and Kidney Transplant Outcomes in African American Patients
This project studies how APOL1 genetic variants in African American donors and recipients affect kidney transplant survival and donor health.
-
APOL1 Kidney Transplantation Outcomes Network Clinical Center
A clinical center part of a nationwide effort to study APOL1 gene effects on long-term kidney transplant success.
-
APOLLO: Understanding APOL1 in Black Americans and Kidney Transplants
This project looks at how APOL1 gene variants affect kidney disease risk and transplant outcomes in Black Americans.
-
ApoL1 Kidney Transplant Outcomes Network study at Johns Hopkins
This project studies how APOL1 gene variants affect kidney transplant results, especially for recipients from donors with African ancestry.
-
APOLLO: Long-term Kidney Transplant Outcomes in African Ancestry
A national network study is following kidney transplant patients and living donors with African ancestry to understand how APOL1 gene variants affect transplant success and kidney function.
-
APOL1 Kidney Transplant Network Clinical Center
This grant supports a national effort to study how APOL1 gene variants affect kidney transplant outcomes, especially in African American donors and recipients.
-
APOL1 and Kidney Transplant Outcomes in African American Donors and Recipients
This program studies how APOL1 gene variants in African American kidney donors and recipients affect long-term transplant success and kidney health after donation.
-
APOL1-Linked Kidney Transplant Outcomes Network (APOLLO) Clinical Center
This grant supports a clinical center that follows kidney transplant patients to understand how APOL1 genetics affect transplant results and living donor health.
-
Racial disparities in access to kidney transplantation
This grant looks at why Black and Hispanic adults have less access to kidney transplantation and how doctors’ communication and clinic interactions may shape those differences.
-
Autologous CAR-T therapy to reduce anti-HLA antibodies before kidney transplant
A patient-facing trial tests a personalized CAR-T cell therapy to lower harmful antibodies that block kidney transplantation in people with end-stage kidney disease.
-
Gut microbes and blood chemicals linked to pain after kidney transplant
This project looks at how changes in gut bacteria and blood metabolites relate to chronic pain in adults after a kidney transplant.
-
Eplet mismatch analysis to improve pediatric kidney transplants
A pediatric kidney transplant research effort is testing whether checking small protein differences (eplets) between donor and recipient can reduce harmful antibodies and improve long-term transplant success.
-
Kidney transplants from HIV-positive donors: impact on rejection and long-term outcomes
This study will compare kidney transplant outcomes for HIV-positive donor to HIV-positive recipient transplants versus HIV-negative donor transplants in people living with HIV.
-
Preventing hepatitis C after receiving a kidney from an HCV-positive donor
This compares two ways of giving hepatitis C antivirals to people getting a kidney from an HCV-positive donor to find which best prevents infection and complications.
-
Promoting Kidney Transplant Acceptance with New Immune Therapies
A large NIH-supported effort at the University of Minnesota is testing new immune-based therapies to help kidney transplant patients avoid lifelong strong immunosuppression.
-
How long the shingles (zoster) vaccine protects people with kidney failure, before and after transplant
This project checks how long the shingles vaccine protects adults with end-stage kidney disease who are waiting for or have received a kidney transplant.
-
How payment incentives affect access to home dialysis and kidney transplant
This project looks at whether changing how dialysis centers are paid helps more patients—especially Black, Hispanic, Native American, and low-income people—get home dialysis or kidney transplants.
-
How immune cells change after a kidney transplant
Researchers are testing ways to block specific immune cell signals to help transplanted kidneys last longer for people who receive kidney transplants.
-
Kidney transplant decisions for people who've had cancer
This project will build a tool to help people with kidney failure who had cancer understand whether a transplant might help them live longer than staying on dialysis.
-
C1 esterase inhibitor injected into deceased-donor kidneys before transplant
This trial tests whether injecting a medicine called C1 esterase inhibitor into donated deceased kidneys before transplant helps adult recipients recover better and have stronger kidney function.
-
Understanding the APOL1 Gene in Kidney Transplants
This project looks at how a gene called APOL1 affects kidney transplant success and the health of African American living kidney donors.
-
Understanding Kidney Transplant Outcomes for Patients of African Ancestry
This research helps us understand why some kidney transplants from donors of African ancestry might not last as long, so we can improve outcomes for patients.
-
Understanding Kidney Transplant Outcomes for People with APOL1 Gene Variations
This project looks at how a specific gene, APOL1, affects the success of kidney transplants, particularly for African Americans, to help improve long-term outcomes for patients.
Related topics
Quick answers
How many Kidney Transplantation clinical trials are recruiting right now?
29, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 14 countries. The most sites are in United States (8 trials), France (5 trials), Spain (3 trials), Belgium (2 trials), Italy (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 4, Phase 2: 3, Phase 4: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.